株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

神経修復用生体材料 (バイオマテリアル) の世界市場:動向・予測

Global Nerve Repair Biomaterials Market - Trends and Forecast to 2024

発行 Data Bridge Market Research Private Limited 商品コード 536504
出版日 ページ情報 英文 229 Pages; 218 Tables; 32 Figures
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.11円で換算しております。
Back to Top
神経修復用生体材料 (バイオマテリアル) の世界市場:動向・予測 Global Nerve Repair Biomaterials Market - Trends and Forecast to 2024
出版日: 2017年05月31日 ページ情報: 英文 229 Pages; 218 Tables; 32 Figures
概要

当レポートでは、世界の神経修復用生体材料 (バイオマテリアル) の市場を調査し、市場の定義と概要、市場への各種影響因子および市場機会の分析、製品タイプ・創傷タイプ・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 市場環境:サマリー

第4章 重要考察

  • 概要
  • 重要考察
  • 市場概要
    • 成長推進因子
    • 成長抑制因子
    • 市場機会
    • 脅威
  • 市場動向・新興技術

第5章 エグゼクティブサマリー

第6章 市場分析:製品タイプ別

  • 概要
  • 神経修復
    • 神経管
    • 神経移植片
  • 神経保護
    • 神経プロテクター
    • 神経ラップ

第7章 市場分析:創傷タイプ別

  • 概要
  • 神経鞘修復
  • 神経周囲修復
  • グループ神経束修復

第8章 市場分析:エンドユーザー別

  • 概要
  • 病院
  • 外来外傷センター
  • 診療所

第9章 地域分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • トルコ
    • ベルギー
    • オランダ
    • スイス
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • 韓国
    • インド
    • オーストラリア
    • シンガポール
    • タイ
    • マレーシア
    • インドネシア
    • フィリピン
    • その他
  • 南米
    • ブラジル
    • その他
  • 中東・アフリカ
    • 南アフリカ
    • その他

第10章 競合環境

  • 企業シェア分析:地域別
  • M&A
  • 新製品の開発・承認
  • 拡張
  • 法規制上の変更
  • 提携・その他

第11章 企業プロファイル

第12章 付録

目次

Synopsis:

Global Nerve Repair Biomaterials Market is expected to reach USD 775.6 million by 2024, at a CAGR of 11.3% during the forecast period of 2017 to 2024. The report contains 203 pages of exclusive premium insights with 218 tables and 32 figures.

The global nerve repair biomaterials market is witnessing a rapid growth due to increasing geriatric population, increasing incidence of nerve injuries and neurological disorders, favourable reimbursement policies, and increased government funding. The demand for nerve repair biomaterials is increasing in the hospitals followed by ambulatory trauma centres due to increasing aging population and rising number of nerve injuries and nerve surgeries.

The Global Nerve Repair Biomaterials Market has been segmented On the basis of product type into nerve repair and nerve protection. The nerve repair biomaterials market is further segmented into nerve conduits and, nerve grafts. Nerve Repair Graft is further segmented into allograft and acellularized allograft. Nerve protection market is segmented into nerve protector and nerve wrap.

On the basis of end user, the nerve repair biomaterial market is categorized into hospitals, clinics, and ambulatory surgical centres.

Based on the injury type, the nerve repair biomaterial market is segmented into epineural nerve repair, perineural nerve repair, and group fascicular repair.

The global nerve repair biomaterials market is segmented into geographical regions, North & South America, Europe, Asia-Pacific and, Middle East & Africa. These regions are further classified on the basis of country, into major countries such as U.S., Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others. The report includes market shares of nerve repair biomaterial market for global, Europe, North America, Asia Pacific and Rest of the World.

Major Players Operating in this market:

Axogen, Inc., Polyganics, B.V., Checkpoint Surgical, Inc. and, Synovis Micro Companies Alliance, Inc. among others.

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))

Table of Contents

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE NERVE REPAIR BIOMATERIALS MARKET
  • 1.2. MARKET SEGMENTATION & COVERAGE
    • 1.2.1. CURRENCY AND PRICING
    • 1.2.2. LIMITATION
    • 1.2.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET SIZE
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6. PORTER'S FIVE FORCES MATRIX
  • 2.4. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT
  • 2.5. ASSUMPTIONS

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. OVERVIEW
  • 4.2. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: KEY PRIMARY INSIGHTS
  • 4.3. MARKET OVERVIEW
    • 4.3.1. DRIVERS
      • 4.3.1.1. INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES
      • 4.3.1.2. TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR
      • 4.3.1.3. FAVORABLE REIMBURSEMENT POLICIES
      • 4.3.1.4. EXPANDED TARGET APPLICATIONS
    • 4.3.2. RESTRAINTS
      • 4.3.2.1. LACK OF PATIENT AWARENESS
      • 4.3.2.2. LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS
    • 4.3.3. OPPURTUNITIES
      • 4.3.3.1. NOVEL THERAPIES SUCH AS STEM CELL THERAPY
      • 4.3.3.2. RISING ACCEPTANCE OF EMERGING MARKETS
    • 4.3.4. THREATS
      • 4.3.4.1. DONOR SITE MORBIDITY
      • 4.3.4.2. INADEQUATE NERVE REGENERATION BY CONDUITS
  • 4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5. EXECUTIVE SUMMARY

6. NERVE REPAIR BIOMATERIALS MARKET, BY PRODUCT TYPE

  • 6.1. OVERVIEW
  • 6.2. NERVE REPAIR
    • 6.2.1. NERVE CONDUITS
    • 6.2.2. NERVE GRAFTS
      • 6.2.2.1. ALLOGRAFTS
      • 6.2.2.2. ACELLULARIZED ALLOGRAFTS
  • 6.3. NERVE PROTECTION
    • 6.3.1. NERVE PROTECTOR
    • 6.3.2. NERVE WRAP

7. NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE

  • 7.1. OVERVIEW
  • 7.2. EPINEURAL NERVE REPAIR
  • 7.3. PERINEURAL NERVE REPAIR
  • 7.4. GROUP FASCICULAR NERVE REPAIR

8. NERVE REPAIR BIOMATERIALS MARKET, BY END USER

  • 8.1. OVERVIEW
  • 8.2. HOSPITALS
  • 8.3. AMBULATORY TRAUMA CENTERS
  • 8.4. CLINICS

9. NERVE REPAIR BIOMATERIALS MARKET, BY GEOGRAPHY

  • 9.1. COUNTRYWISE NERVE REPAIR BIOMATERIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • 9.1.1. NORTH AMERICA
      • 9.1.1.1. U.S.
      • 9.1.1.2. CANADA
      • 9.1.1.3. MEXICO
    • 9.1.2. EUROPE
      • 9.1.2.1. GERMANY
      • 9.1.2.2. FRANCE
      • 9.1.2.3. U.K.
      • 9.1.2.4. ITALY
      • 9.1.2.5. SPAIN
      • 9.1.2.6. RUSSIA
      • 9.1.2.7. TURKEY
      • 9.1.2.8. BELGIUM
      • 9.1.2.9. NETHERLANDS
      • 9.1.2.10. SWITZERLAND
      • 9.1.2.11. REST OF EUROPE
    • 9.1.3. ASIA-PACIFIC (APAC)
      • 9.1.3.1. JAPAN
      • 9.1.3.2. CHINA
      • 9.1.3.3. SOUTH KOREA
      • 9.1.3.4. INDIA
      • 9.1.3.5. AUSTRALIA
      • 9.1.3.6. SINGAPORE
      • 9.1.3.7. THAILAND
      • 9.1.3.8. MALAYSIA
      • 9.1.3.9. INDONESIA
      • 9.1.3.10. PHILIPPINES
      • 9.1.3.11. REST OF APAC
    • 9.1.4. LATIN AMERICA
      • 9.1.4.1. BRAZIL
      • 9.1.4.2. REST OF LATIN AMERICA
    • 9.1.5. MIDDLE EAST AND AFRICA
      • 9.1.5.1. SOUTH AFRICA
      • 9.1.5.2. REST OF MIDDLE EAST AND AFRICA
  • 9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. NERVE REPAIR BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE

  • 10.1. GLOBAL NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.2. U.S. NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.3. EUROPE NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.4. APAC NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.5. SOUTH AMERICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.6. MIDDLE EAST AND AFRICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
  • 10.7. MERGERS & ACQUISITIONS
  • 10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 10.10. EXPANSIONS
  • 10.10. REGULATORY CHANGES
  • 10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11. NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES

  • 11.1. AXOGEN, INC.
    • 11.1.1. COMPANY OVERVIEW
    • 11.1.2. SWOT ANALYSIS
    • 11.1.3. REVENUE ANALYSIS
    • 11.1.4. PRODUCT PORTFOLIO
    • 11.1.5. RECENT DEVELOPEMENTS
    • 11.1.5. DATA BRIDGE ANALYSIS
  • 11.2. CHECKPOINT SURGICAL, INC.
    • 11.2.1. COMPANY OVERVIEW
    • 11.2.2. SWOT ANALYSIS
    • 11.2.3. REVENUE ANALYSIS
    • 11.2.4. PRODUCT PORTFOLIO
    • 11.2.5. RECENT DEVELOPEMENTS
    • 11.2.5. DATA BRIDGE ANALYSIS
  • 11.3. COLLAGEN MATRIX, INC.
    • 11.3.1. COMPANY OVERVIEW
    • 11.3.2. SWOT ANALYSIS
    • 11.3.3. REVENUE ANALYSIS
    • 11.3.4. PRODUCT PORTFOLIO
    • 11.3.5. RECENT DEVELOPEMENTS
    • 11.3.5. DATA BRIDGE ANALYSIS
  • 11.4. INTEGRA LIFESCIENCES CORPORATION
    • 11.4.1. COMPANY OVERVIEW
    • 11.4.2. SWOT ANALYSIS
    • 11.4.3. REVENUE ANALYSIS
    • 11.4.4. PRODUCT PORTFOLIO
    • 11.4.5. RECENT DEVELOPEMENTS
    • 11.4.5. DATA BRIDGE ANALYSIS
  • 11.5. POLYGANICS B.V.
    • 11.5.1. COMPANY OVERVIEW
    • 11.5.2. SWOT ANALYSIS
    • 11.5.3. REVENUE ANALYSIS
    • 11.5.4. PRODUCT PORTFOLIO
    • 11.5.5. RECENT DEVELOPEMENTS
    • 11.5.5. DATA BRIDGE ANALYSIS
  • 11.6. STRYKER CORPORATION
    • 11.6.1. COMPANY OVERVIEW
    • 11.6.2. SWOT ANALYSIS
    • 11.6.3. REVENUE ANALYSIS
    • 11.6.4. PRODUCT PORTFOLIO
    • 11.6.5. RECENT DEVELOPEMENTS
    • 11.6.5. DATA BRIDGE ANALYSIS
  • 11.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC.
    • 11.7.1. COMPANY OVERVIEW
    • 11.7.2. SWOT ANALYSIS
    • 11.7.3. REVENUE ANALYSIS
    • 11.7.4. PRODUCT PORTFOLIO
    • 11.7.5. RECENT DEVELOPEMENTS
    • 11.7.5. DATA BRIDGE ANALYSIS

12. APPENDIX

13. ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top